EicOsis Human Health Inc.
7 clinical trials · Sponsor
◉ Watch EicOsis Human Health Inc.
| Record | Firm | Date |
|---|---|---|
| Renal Impairment Study for Oral EC5026 (NCT07694544) | EicOsis Human Health Inc. | 2026-07-01 |
| Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury (NCT06438471) | EicOsis Human Health Inc. | 2026-05-01 |
| Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study) (NCT07142044) | EicOsis Human Health Inc. | 2025-11-01 |
| Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Oral EC5026 in Healthy Subjects (NCT06089837) | EicOsis Human Health Inc. | 2023-11-28 |
| Safety, Tolerability, Pharmacokinetics and Food Effects of Oral EC5026 in Healthy Subjects (NCT04908995) | EicOsis Human Health Inc. | 2021-04-30 |
| Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19) (NCT04452942) | EicOsis Human Health Inc. | 2020-07-01 |
| Safety, Tolerability, and Pharmacokinetics of Oral EC5026 in Healthy Subjects (NCT04228302) | EicOsis Human Health Inc. | 2019-12-09 |
Track EicOsis Human Health Inc. automatically
Every clearance here is in the API, with alerts when new ones post.